Zentalis Pharmaceuticals, Inc.

NASDAQ:ZNTL

2.78 (USD) • At close January 8, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Omzet 0040.562.1040000000000000000000
Kosten van de omzet 00.3270.3240.3370.3480.3440.360.3590.3750.3480.3440.2090.1370.1190.07900000000
Brutowinst 0-0.32740.2361.767-0.348-0.344-0.36-0.359-0.375-0.348-0.344-0.209-0.137-0.119-0.07900000000
Brutowinstmarge 000.9920.840000000000000000000
Onderzoek- en ontwikkelingskosten 36.82448.38649.58551.55746.76542.68448.58440.61642.18143.82546.11238.43953.99844.7738.39429.52124.6717.45213.25811.86910.7398.6897.089
Algemene en administratieve kosten 14.60816.76215.7416.36515.95315.66416.36911.13812.01219.63611.7679.7548.87210.36211.95310.72410.0979.9243.1413.0361.8441.9461.633
Verkoop- en marketingkosten 00-0.324-0.3370000000000000000000
Verkoop-, algemene en administratieve kosten 14.60816.76215.41616.02815.95315.66416.36911.13812.01219.63611.7679.7548.87210.36211.95310.72410.0979.9243.1413.0361.8441.9461.633
Overige kosten 0000045.56800000000-0.0440000000-0.012
Bedrijfskosten 51.43265.14865.00167.58562.71858.34864.95351.75454.19363.46157.87948.19362.8755.13250.34740.24534.76727.37616.39914.90512.58310.6358.722
Bedrijfsresultaat -51.432-65.148-24.765-67.922-62.718-103.916-64.953-51.754-54.193-63.461-57.879-48.193-62.87-55.132-50.347-40.245-34.767-27.376-16.399-14.905-12.583-10.635-8.722
Bedrijfsresultaat ratio 00-0.611-32.2820000000000000000000
Totaal overige inkomsten en kosten netto 11.247-22.86334.9486.8487.209-41.1174.1093.2321.9050.4240.4260.08851.6810.1150.0990.3150.120.0840.1640.3590.0120.0490.062
Inkomen voor belasting -40.185-88.01110.183-61.074-55.509-99.465-60.844-48.522-52.288-63.037-57.453-48.105-11.189-55.017-50.248-39.93-34.647-27.292-16.235-14.546-12.571-10.586-8.66
Inkomen voor belasting ratio 000.251-29.0280000000000000000000
Belastingkosten -0.0270.2660.143-0.1350.031-0.6050.108-0.36-0.1590.0170.0330.159-0.6970.0450.1960.4260.018-0.435-0.109-0.5380.0010.0110.003
Nettowinst -40.158-88.27710.068-60.917-55.528-112.527-60.952-48.162-52.129-63.054-57.486-50.059-4.191-54.574-49.901-40.303-34.555-26.857-16.126-14.506-12.344-10.47-8.343
Nettowinstmarge 000.248-28.9530000000000000000000
WPA (Winst Per Aandeel) -0.56-1.240.14-0.86-0.79-1.85-1.03-0.81-0.92-1.23-1.27-1.11-0.094-1.34-1.24-1.01-0.91-0.78-0.47-0.44-0.68-0.58-0.46
Verwaterde WPA -0.56-1.240.14-0.86-0.79-1.85-1.03-0.81-0.92-1.23-1.27-1.11-0.094-1.34-1.24-1.01-0.91-0.78-0.47-0.42-0.68-0.58-0.46
EBITDA -51.111-65.148-24.441-67.585-62.37-58.004-64.593-51.395-53.818-63.113-57.535-47.896-62.733-55.013-50.268-40.212-34.716-27.338-16.361-14.864-12.558-10.611-8.701
EBITDA ratio 00-0.603-32.1220000000000000000000